|
|
|
| Webinar: Supporting Efficient mAb Development with a Flexible Downstream Purification Toolkit | Accelerating antibody therapeutics to market requires more than upstream performance. As mAb formats grow more complex, downstream purification must evolve beyond traditional approaches. This webinar explores flexible purification strategies, advanced chromatography options, and buffer optimization techniques to improve yield, purity, and robustness. Learn how to streamline process development and build a purification toolkit that supports faster biologics manufacturing. Click here to learn more. |
|
|
|
|
A conversation with Gabriel Cook, Oklahoma State University, and Life Science Connect's Executive Editor Jon O'Connell | Post-translational modifications of membrane proteins have been historically challenging. Research shows how an in vitro approach brings stability and predictability. | |
|
|
| Advancing Chronic Care Through GLP‑1 Innovation | White Paper | Kindeva | GLP‑1 therapies are changing injectable care and driving rapid progress in delivery and manufacturing. See how patient needs, emerging tech, and regulations are reshaping chronic treatment. |
|
|
| Thermal Stability Technology Selection Guide | E-Book | TA Instruments | Thermal stability testing is essential for biologics development to help ensure safety and efficacy. Learn how thermal data supports candidate selection, formulation, and storage decisions. |
|
|
|
|
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
Aligning Upstream And Downstream Development (Part 2) | By Bioprocess Online Live | In Part 2 of this conversation on “Better Biopharma,” panelists from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration” continue their discussion about how upstream and downstream development teams can work together to accelerate timelines and reduce risk and bottlenecks in process development. |
|
|
| Ensure Successful Viral Clearance | Webinar | WuXi Biologics | A decade of viral clearance data compares established and emerging operations, highlighting LRV performance, key process risks, and practical insights to strengthen downstream safety. |
|
|
| Rapid Process Development For Cell Line Optimization Using Protein A | Application Note | By Jess Kettner, Jeffrey Cassel, and William Barrett, Ph.D., W.L. Gore & Associates | Rapidly purify 24 monoclonal antibody samples in under eight hours with a membrane-based affinity capture that streamlines cell line optimization and accelerates early-stage bioprocess development. |
|
|
| Scalability And Reproducibility Of The AAV9 Capture Step | Application Note | Repligen | Scaling gene therapies beyond rare diseases demands innovation. Discover a chromatography system that boosts efficiency, protects product integrity, and overcomes viral vector manufacturing challenges. |
|
|
| Beyond Traditional Monoclonal Antibodies | White Paper | Ecolab, Purolite™ Resins | New antibody formats present new purification challenges due to novel impurity profiles. New methods and media are required to ensure safe, effective, and scalable manufacturing of these biologics. |
|
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
